Bioavailability assessing

Welling, P.G. Deobrinska, M.R. "Dosing considerations and bioavailability assessment of controlled drug delivery systems" In Controlled Drug Delivery Robinson, J.R., Lee, V.H.L., Eds. Drugs and the Pharmaceutical Sciences M. Dekker, New York, NY, 1987, Vol. 29, pp. 253-292. 

Bioavailability Assessment through the Use of In Vitro Assays and Values Associated with Moderate to Good Bioavailability... 

Absolute bioavailability assessed in HIV-positive patients averaged 20%. Somewhat reduced drug distribution and faster drug elimination in compromised renal function may result in decreased drug concentrations. 

GN168 Pabon, M. L., and B. Lonnerdal. Effects of type of fat in the diet on iron bioavailability assessed in suckling and weanling rats. J Trace Elem Med Biol 2001 15(1) 18-23. 

Hussain, A. S. (2006), Quality by design and bioequivalence/bioavailability assessment, paper presented at the The Heidelberg PAT Conference 2006, Heidelberg, Germany. 

Kommuru, T.R., Gurley, B., Khan, M.A., Reddy, I.K. (2001). Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10 formulation development and bioavailability assessment. International Journal of Pharmaceutics, 212, 233-246. 

Khoo, S.-M. et al. (1998) Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrindnt. J. Pharm., 167 155-164. 

Zaghloul A. A., B. Gurley, M. Khan, H. Bhagavan, R. Chopra, and I. Reddy. 2002. Bioavailability assessments of oral coenzyme Q10 formulations in docjSrug Development and Indusrtial Pharmacy, 28(10) 1195-1200. 

Houba VGJ, Lexmond TM, Novozamsky I, Van der Lee JJ. 1996. State of the art and future developments in soil analysis for bioavailability assessment. Sci Total Environ 178 21-28. 

Welling, P. G., and Dobrinska, M. R. (1987), Dosing considerations and bioavailability assessment of controlled drug delivery systems, in Controlled Drug Delivery Fundamentals and Applications, Marcel Dekker, New York, pp. 253-289. 

The use of GC was first included in the United States Pharmacopoeia (USP) in the sixteenth edition in 1960, and became an official method of the British Pharmacopoeia (BP) in 1968. GC has found widespread use in pharmaceutical analysis by virtue of its applications to purity and control analysis of raw materials, content and quality assessment of dosage forms (including product stability), and in the quantitative measurement of drugs in biological fluids. The latter application is important for therapeutic drug monitoring, pharmacokinetic studies, and bioavailability assessments. In fact, in a survey on GC use, ° a major application of this technique was in the field of pharmaceuticals. 

B. Timmermann/U. of Arizona Curcuma longa rhizome (turmeric), Zingiber Officinale Rhizome (ginger), Boswellia serrata (boswellin) Determine the active components and their ability to regulate inflammation Characterize the disposition, gastrointestinal absorption kinetics, and bioavailability Assess the pharmacokinetic and pharmacodynamic characteristics In vitro Animals Phase I trial... 

Pore water assessments evaluate the toxicity of the interstitial water of the sediment to the aquatic organism (Mayer, 1993). The interstitial water is removed from the sediment by sediment compression or centrifugation. The advantage of this assessment is that the equilibrium of the sediment/water interface is more closely evaluated toxicologically, which allows more confidence in the bioavailability assessment. However, toxicity artifacts such as ammonia and sulfide... 

Ritschel, W. A. 1987. In vivo animal models for bioavailability assessment. S.T.P. Pharma. 3 125-141. 

Type 3 To determine the bioavailability of substances or pollutants during the transport of particulate matter through rivers and reservoirs (bioavailability assessment). 

---